| 产品描述: | Ticagrelor metabolite M5 is a metabolite of Ticagrelor, the first reversible oral antagonist of P2Y12 receptor. Compared to Clopidogrel, Ticagrelor has faster and more consistent inhibition on ADP-receptors. Ticagrelor is used in the treatment of acute coronary syndromes (ACS). |
| 靶点: |
P2Y Receptor;P2YReceptor |
| 参考文献: |
1. Teng R, Oliver S, Hayes MA, Butler K. Absorption, distribution, metabolism, and excretion of ticagrelor in healthy subjects. Drug Metab Dispos. 2010 Sep;38(9):1514-21. doi: 10.1124/dmd.110.032250. Epub 2010 Jun 15. PubMed PMID: 20551239. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-20℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.7 ml |
13.498 ml |
26.996 ml |
| 5 mM |
0.54 ml |
2.7 ml |
5.399 ml |
| 10 mM |
0.27 ml |
1.35 ml |
2.7 ml |
| 50 mM |
0.054 ml |
0.27 ml |
0.54 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |